等待开盘 11-05 09:30:00 美东时间
-0.530
-22.18%
黄金矿业股集体大涨,三倍做多ETN飙升27.23%;做多Moderna ETF涨25.57%,新药研发取得进展;做多Cipher ETF跌40.21%,AI数据中心股遭抛售
今天 08:31
Leverage Shares每日2倍做多IREN主动型ETF跌15.06%,报2.03美元
11-04 11:02
Leverage Shares每日2倍做多IREN主动型ETF跌10.04%,报2.15美元
11-04 09:21
Leverage Shares每日2倍做多IREN主动型ETF暴泻10.21%,报2.55美元
11-02 08:19
Leverage Shares每日2倍做多IREN主动型ETF急跌10.21%,报2.55美元
11-02 08:08
Leverage Shares每日2倍做多IREN主动型ETF暴泻10.21%,报2.55美元
11-02 08:01
2倍做多PURR ETF暴升47%,传奇基金经理宣布入股TradeXYZ;1倍做空谷歌ETF升近13%,3倍做空纳指ETF升逾4%,谷歌AI扩张遇阻>>
10-30 16:08
Leverage Shares每日2倍做多IREN主动型ETF跌10.92%,报2.53美元
10-30 08:21
Merck’s Q3 2026 revenue rose 5% to $18.09 billion, led by KEYTRUDA, WINREVAIR, GARDASIL and Animal Health, while GAAP EPS fell 12% to $2.04 and non-GAAP EPS declined 3% to $2.49. GAAP gross margin narrowed to 72.9% as higher R&D, launch spending, intangible amortization, restructuring and net interest expense outweighed sales growth. Merck narrowed its full-year sales outlook to $66.8 billion-$67.3 billion and raised its non-GAAP EPS range to $2.
10-29 10:43
Leverage Shares每日2倍做多IREN主动型ETF跌10.09%,报3.12美元
10-29 10:22